Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors.

Schafer JM, Lehmann BD, Gonzalez-Ericsson PI, Marshall CB, Beeler JS, Redman LN, Jin H, Sanchez V, Stubbs MC, Scherle P, Johnson KN, Sheng Q, Roland JT, Bauer JA, Shyr Y, Chakravarthy B, Mobley BC, Hiebert SW, Balko JM, Sanders ME, Liu PCC, Pietenpol JA
Sci Transl Med. 2020 12 (534)

PMID: 32161105 · PMCID: PMC7427123 · DOI:10.1126/scitranslmed.aaw8275

MeSH Terms (9)

Animals Cell Line, Tumor Humans Mitogen-Activated Protein Kinase Kinases N-Myc Proto-Oncogene Protein Neoplasm Recurrence, Local Proteins Triple Negative Breast Neoplasms Xenograft Model Antitumor Assays

Connections (1)

This publication is referenced by other Labnodes entities: